Table 3.
Univariable competing‐risk regression analysis for SCA
| Variables | HR (95%CI) | P |
|---|---|---|
| Sex | 0.444 (0.119–1.654) | ns |
| Age | 1.078 (0.961–1.209) | ns |
| Smoking | 0.230 (0.059–0.890) | .033 |
| Hypertension | 0.576 (0.168–1.973) | ns |
| Diabetes | 0.729 (0.162–3.273) | ns |
| eGFR | 0.977 (0.955–0.999) | .048 |
| LVEF | 0.972 (0.916–1.031) | ns |
| Grace score | 1.018 (0.995–1.043) | ns |
| SDNN | 0.967 (0.942–0.993) | .012 |
| VLF | 0.998 (0.996–0.999) | .027 |
| DC | 0.580 (0.445–0.754) | <0.001 |
| SDNN a | 5.545 (1.474–20.861) | .011 |
| VLF a | 13.650 (1.743–106.862) | .013 |
| DC a | 8.580 (2.410–30.551) | .001 |
| DRs risk stratification | 4.142 (2.554–6.717) | <.001 |
Abbreviations: DC, deceleration capacity of heart rate; DRs, deceleration runs of heart rate; eGFR, estimated glomerular filtration rate; ns, no significance; SDNN, standard deviation of normal to normal RR intervals; VLF, very low frequency.
a
Dichotomous variable: variables split by the cut‐off values.